Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Issues and Questions Surrounding Screening for Cognitive Impairment in Older Patients

Issues and Questions Surrounding Screening for Cognitive Impairment in Older Patients Opinion EDITORIAL Issues and Questions Surrounding Screening for Cognitive Impairment in Older Patients Ronald C. Petersen, PhD, MD; Kristine Yaffe, MD The importance of addressing age-associated cognitive im- followed up for up to 12 months, it might be difficult to inter- pairment cannot be overstated. The rising prevalence of cog- pret any effect on decision-making, patient-family/caregiver, or societal outcomes in relatively few participants over a brief nitive impairment such as mild cognitive impairment (MCI) and dementia, including Alzheimer disease, is becoming a world- period. Therefore, while this RCT was the only study found wide concern. In this issue of for key question 1, it is clear that the trial could not resolve JAMA, the US Preventive Ser- many of the questions it was designed to address. Related articles pages 757 and vices Task Force (USPSTF) The second key question pertained to the accuracy 764 and JAMA Patient Page concludes that “the current of screening instruments to detect cognitive impairment. page 800 evidence is insufficient to as- Many of these instruments are brief, which is necessitated sess the balance of benefits by the time pressures of a primary care practice and, as such, Audio and harms of screening for the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Issues and Questions Surrounding Screening for Cognitive Impairment in Older Patients

JAMA , Volume 323 (8) – Feb 25, 2020

Loading next page...
 
/lp/american-medical-association/issues-and-questions-surrounding-screening-for-cognitive-impairment-in-KNdtHkcGwi

References (14)

Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2019.22527
Publisher site
See Article on Publisher Site

Abstract

Opinion EDITORIAL Issues and Questions Surrounding Screening for Cognitive Impairment in Older Patients Ronald C. Petersen, PhD, MD; Kristine Yaffe, MD The importance of addressing age-associated cognitive im- followed up for up to 12 months, it might be difficult to inter- pairment cannot be overstated. The rising prevalence of cog- pret any effect on decision-making, patient-family/caregiver, or societal outcomes in relatively few participants over a brief nitive impairment such as mild cognitive impairment (MCI) and dementia, including Alzheimer disease, is becoming a world- period. Therefore, while this RCT was the only study found wide concern. In this issue of for key question 1, it is clear that the trial could not resolve JAMA, the US Preventive Ser- many of the questions it was designed to address. Related articles pages 757 and vices Task Force (USPSTF) The second key question pertained to the accuracy 764 and JAMA Patient Page concludes that “the current of screening instruments to detect cognitive impairment. page 800 evidence is insufficient to as- Many of these instruments are brief, which is necessitated sess the balance of benefits by the time pressures of a primary care practice and, as such, Audio and harms of screening for the

Journal

JAMAAmerican Medical Association

Published: Feb 25, 2020

There are no references for this article.